Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.523ORF1abCN-CDC-ORF1abCCCTGTGGGTTTTACACTTAA2142.861334213362F-16119.8China
DV.7.1.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-16141.5Germany
AY.4.2.1 (Delta)NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-16142.4Hong Kong
BA.2.3.7NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-16150.4Hong Kong
B.1.1.236NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-16150.4Hong Kong
BA.2.75.7NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-16156.5China
XBB.1.5.91SNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-16158.4Japan
GS.4.1ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-16167.4Japan
B.1.369ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-16167.4Japan
GS.4.1.1ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-16167.4Japan
B.1.243ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-16167.4Japan
GS.4ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-16167.4Japan
KF.1ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-16167.4Japan
B.1.243.2ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-16167.4Japan
P.6SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-16180Japan
XBB.2.9SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-16180Japan
B.1.1.318SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-16180Japan
AZ.2.1SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-16180Japan
XBB.1.5.21SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-16180Japan
GW.1SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-16180Japan
BA.5.1.7SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-16180Japan
B.1.1.282SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-16180Japan
BF.29SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-16180Japan
AZ.3SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-16180Japan
AZ.1SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-16180Japan
B.1.1.187SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-16180Japan
XBB.3SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-16180Japan
AZ.5SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-16180Japan
AZ.2SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-16180Japan
B.1.357NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-16188.7Japan
B.1.37NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-16188.7Japan
DQ.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-16188.7Japan
B.1.595.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-16197.2US
AY.21 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-16197.2US
AD.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-16197.2US
AD.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-16197.2US
B.1.1.315NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-16197.2US
JM.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-16197.2US
GA.4.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-16197.2US
BA.2.75.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-16208.9France
FF.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-16218.9China
XBC.1.3ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-16270.2Germany
AY.105 (Delta)SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-16270.5Japan
B.1.590ENiu-ECACGTTAACAATATTGCAGC20402639126372R-16283.8China
KP.4.2.2NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-16323.9Hong Kong
JC.1ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-16329.3Japan
JG.4SNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-16333.7Japan
XBB.1.6SNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-16333.7Japan
BM.2ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-16340.7France
B.1.532NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-16341.6US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used